Please use this identifier to cite or link to this item:
https://hdl.handle.net/10356/164086| Title: | Effectiveness of BNT162b2 vaccine against omicron in children 5 to 11 years of age | Authors: | Tan, Sharon H. X. Cook, Alex R. Heng, Derrick Ong, Benjamin Lye, David C. Tan, Kelvin B. |
Keywords: | Science::Medicine | Issue Date: | 2022 | Source: | Tan, S. H. X., Cook, A. R., Heng, D., Ong, B., Lye, D. C. & Tan, K. B. (2022). Effectiveness of BNT162b2 vaccine against omicron in children 5 to 11 years of age. New England Journal of Medicine, 387(6), 525-532. https://dx.doi.org/10.1056/NEJMoa2203209 | Journal: | New England Journal of Medicine | Abstract: | Since it was first identified in early November 2021, the B.1.1.529 (omicron) variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread quickly and replaced the B.1.617.2 (delta) variant as the dominant variant in many countries. Data on the real-world effectiveness of vaccines against the omicron variant in children are lacking. | URI: | https://hdl.handle.net/10356/164086 | ISSN: | 0028-4793 | DOI: | 10.1056/NEJMoa2203209 | Rights: | © 2022 Massachusetts Medical Society. All rights reserved. | Fulltext Permission: | none | Fulltext Availability: | No Fulltext |
| Appears in Collections: | LKCMedicine Journal Articles |
SCOPUSTM
Citations
20
16
Updated on Feb 3, 2023
Web of ScienceTM
Citations
20
15
Updated on Feb 6, 2023
Page view(s)
21
Updated on Feb 6, 2023
Google ScholarTM
Check
Altmetric
Items in DR-NTU are protected by copyright, with all rights reserved, unless otherwise indicated.